Skip to Content
You are currently on the new version of our website. Access the old version .

Cancers, Volume 3, Issue 2

2011 June - 70 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (70)

  • Review
  • Open Access
90 Citations
21,182 Views
44 Pages

23 June 2011

Prediction of prognosis in colorectal cancer is vital for the choice of therapeutic options. Histopathological factors remain paramount in this respect. Factors such as tumor size, histological type and subtype, presence of signet ring morphology and...

  • Article
  • Open Access
7 Citations
9,795 Views
17 Pages

22 June 2011

Genetic abnormalities such as nucleotide alterations and chromosomal disorders that accumulate in various tumor-related genes have an important role in cancer development. The precise mechanism of the acquisition of genetic aberrations, however, rema...

  • Review
  • Open Access
19 Citations
9,575 Views
16 Pages

TRAF4, at the Crossroad between Morphogenesis and Cancer

  • Adrien Rousseau,
  • Marie-Christine Rio and
  • Fabien Alpy

21 June 2011

Tumor Necrosis Factor Receptor-Associated Factor 4 (TRAF4) is a gene whose expression is altered in cancers. It is overexpressed in a variety of carcinomas of different origins, often as a consequence of amplification. TRAF4 encodes an adaptor protei...

  • Review
  • Open Access
7 Citations
8,133 Views
13 Pages

20 June 2011

The cancer stem cell model introduces new strategies for the prevention and treatment of cancers. In cancers that appear to follow the stem cell model, pathways such as Wnt, Notch and Hedgehog may be targeted with natural compounds such as curcumin o...

  • Review
  • Open Access
20 Citations
9,716 Views
25 Pages

20 June 2011

The Alpha-fetoprotein (AFP) derived Growth Inhibitory Peptide (GIP) is a 34-amino acid segment of the full-length human AFP molecule that inhibits tumor growth and metastasis. The GIP-34 and its carboxy-terminal 8-mer segment, termed GIP-8, were foun...

  • Article
  • Open Access
4 Citations
9,454 Views
17 Pages

Metastasizing, Luciferase Transduced MAT‑Lu Rat Prostate Cancer Models: Follow up of Bolus and Metronomic Therapy with Doxorubicin as Model Drug

  • Peter Jantscheff,
  • Norbert Esser,
  • Andreas Geipel,
  • Peter Woias,
  • Vittorio Ziroli,
  • Frank Goldschmidtboing and
  • Ulrich Massing

17 June 2011

The most fatal outcomes of prostate carcinoma (PCa) result from hormone-refractory variants of the tumor, especially from metastatic spread rather than from primary tumor burden. The goal of the study was to establish and apply rat MAT-Lu prostate ca...

  • Review
  • Open Access
34 Citations
11,139 Views
12 Pages

Glioblastoma Stem-Like Cells—Biology and Therapeutic Implications

  • Demirkan B. Gürsel,
  • Benjamin J. Shin,
  • Jan-Karl Burkhardt,
  • Kartik Kesavabhotla,
  • Cody D. Schlaff and
  • John A. Boockvar

10 June 2011

The cancer stem-cell hypothesis proposes that malignant tumors are likely to encompass a cellular hierarchy that parallels normal tissue and may be responsible for the maintenance and recurrence of glioblastoma multiforme (GBM) in patients. The purpo...

  • Review
  • Open Access
6 Citations
7,961 Views
12 Pages

10 June 2011

Lung cancer is the leading cause of cancer-related deaths worldwide. Non-small-cell lung cancer (NSCLC) cases comprise approximately 85% of the lung cancer cases. Before the era of target therapy, platinum-based doublet chemotherapy only led to a med...

  • Review
  • Open Access
44 Citations
11,047 Views
43 Pages

State of the Art in Tumor Antigen and Biomarker Discovery

  • Klervi Even-Desrumeaux,
  • Daniel Baty and
  • Patrick Chames

9 June 2011

Our knowledge of tumor immunology has resulted in multiple approaches for the treatment of cancer. However, a gap between research of new tumors markers and development of immunotherapy has been established and very few markers exist that can be used...

  • Review
  • Open Access
115 Citations
10,789 Views
33 Pages

9 June 2011

Combination therapy is a common practice in many medical disciplines. It is defined as the use of more than one drug to treat the same disease. Sometimes this expression describes the simultaneous use of therapeutic approaches that target different c...

  • Review
  • Open Access
168 Citations
15,376 Views
25 Pages

Regulation of Autophagy by Kinases

  • Savitha Sridharan,
  • Kirti Jain and
  • Alakananda Basu

9 June 2011

Autophagy is a process of self-degradation that maintains cellular viability during periods of metabolic stress. Although autophagy is considered a survival mechanism when faced with cellular stress, extensive autophagy can also lead to cell death. A...

  • Article
  • Open Access
19 Citations
9,301 Views
14 Pages

8 June 2011

In spite of optimal local control in breast cancer, distant metastases can develop as a systemic part of this disease. Surgery is suspected to contribute to metastasis formation activating dormant tumor cells. Here we add data that seeding of cells d...

  • Review
  • Open Access
629 Citations
25,783 Views
24 Pages

Cell Death Pathways in Photodynamic Therapy of Cancer

  • Pawel Mroz,
  • Anastasia Yaroslavsky,
  • Gitika B Kharkwal and
  • Michael R. Hamblin

3 June 2011

Photodynamic therapy (PDT) is an emerging cancer therapy that uses the combination of non-toxic dyes or photosensitizers (PS) and harmless visible light to produce reactive oxygen species and destroy tumors. The PS can be localized in various organel...

  • Article
  • Open Access
5 Citations
9,668 Views
15 Pages

Activation of PDGFr-β Signaling Pathway after Imatinib and Radioimmunotherapy Treatment in Experimental Pancreatic Cancer

  • Michio Abe,
  • Zbigniew P. Kortylewicz,
  • Charles A. Enke,
  • Elizabeth Mack and
  • Janina Baranowska-Kortylewicz

25 May 2011

Pancreatic cancer does not respond to a single-agent imatinib therapy. Consequently, multimodality treatments are contemplated. Published data indicate that in colorectal cancer, imatinib and radioimmunotherapy synergize to delay tumor growth. In pan...

  • Review
  • Open Access
49 Citations
11,166 Views
23 Pages

24 May 2011

Over the last decade, extensive studies have been made to understand the role played by the mammalian target of rapamycin (mTOR) in cancer. Knowledge in this field has been gained from discoveries in basic research as well as from observations made i...

  • Review
  • Open Access
87 Citations
11,731 Views
16 Pages

20 May 2011

The development and maintenance of defining features of cancer, such as unremitting cell proliferation, evasion of programmed cell death, and the capacity for colonizing local tissues and distant organs, demand a massive production of structural, sig...

  • Article
  • Open Access
26 Citations
9,416 Views
23 Pages

18 May 2011

Seven different radiobiological dose-response models have been compared with regard to their ability to describe experimental data. The first four models, namely the critical volume, the relative seriality, the inverse tumor and the critical element...

  • Review
  • Open Access
69 Citations
12,914 Views
18 Pages

Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer

  • Carmen Berasain,
  • María Ujue Latasa,
  • Raquel Urtasun,
  • Saioa Goñi,
  • María Elizalde,
  • Oihane Garcia-Irigoyen,
  • María Azcona,
  • Jesús Prieto and
  • Matías A. Ávila

18 May 2011

Hepatocarcinogenesis is a complex multistep process in which many different molecular pathways have been implicated. Hepatocellular carcinoma (HCC) is refractory to conventional chemotherapeutic agents, and the new targeted therapies are meeting with...

  • Review
  • Open Access
36 Citations
12,268 Views
19 Pages

Differentiation Therapy of Acute Myeloid Leukemia

  • Elzbieta Gocek and
  • Ewa Marcinkowska

16 May 2011

Acute Myeloid Leukemia (AML) is a predominant acute leukemia among adults, characterized by accumulation of malignantly transformed immature myeloid precursors. A very attractive way to treat myeloid leukemia, which is now called ‘differentiation the...

  • Review
  • Open Access
34 Citations
10,749 Views
24 Pages

13 May 2011

There has been no systematic appraisal of ethnicity-based variations in breast cancer (BC) biology amongst women from developing countries. A qualitative systematic review was conducted of breast cancer size, stage, grade, histological type, extra-ma...

  • Review
  • Open Access
34 Citations
9,343 Views
20 Pages

13 May 2011

There has been no systematic appraisal of ethnicity-based variations in breast cancer (BC) biology amongst women from developing countries. A qualitative systematic review was conducted of breast cancer size, stage, grade, histological type, extra-ma...

  • Review
  • Open Access
8 Citations
8,980 Views
14 Pages

The Role of High Frequency Dynamic Threshold (HiDT) Serum Carcinoembryonic Antigen (CEA) Measurements in Colorectal Cancer Surveillance: A (Revisited) Hypothesis Paper

  • Irene Grossmann,
  • Charlotte Verberne,
  • Geertruida De Bock,
  • Klaas Havenga,
  • Ido Kema,
  • Joost Klaase,
  • Andrew Renehan and
  • Theo Wiggers

11 May 2011

Following curative treatment for colorectal cancer (CRC), 30% to 50% of patients will develop recurrent disease. For CRC there are several lines of evidence supporting the hypothesis that early detection of metachronous disease offers a second opport...

  • Article
  • Open Access
13 Citations
8,776 Views
17 Pages

Different Aspects of Self-Reported Quality of Life in 450 German Melanoma Survivors

  • Annika Waldmann,
  • Sandra Nolte,
  • Ron Pritzkuleit,
  • Eckhard W. Breitbart and
  • Alexander Katalinic

11 May 2011

The present study was aimed at assessing quality of life (QoL) in a total of 450 melanoma patients who filled out the EORTC QLQ-C30 (Q1; 15 months post diagnosis) as part of the OVIS Study. Follow-up questionnaires (Q2) were administered two years af...

  • Review
  • Open Access
103 Citations
16,412 Views
25 Pages

Tomato Lycopene and Lung Cancer Prevention: From Experimental to Human Studies

  • Paola Palozza,
  • Rossella E. Simone,
  • Assunta Catalano and
  • Maria Cristina Mele

11 May 2011

Increasing evidence suggests that tomato lycopene may be preventive against the formation and the development of lung cancer. Experimental studies demonstrated that lycopene may inhibit the growth of several cultured lung cancer cells and prevent lun...

  • Article
  • Open Access
2 Citations
8,771 Views
16 Pages

Neoadjuvant Therapy in Patients with Pancreatic Cancer: A Disappointing Therapeutic Approach?

  • Carolin Zimmermann,
  • Gunnar Folprecht,
  • Daniel Zips,
  • Christian Pilarsky,
  • Hans Detlev Saeger and
  • Robert Grutzmann

9 May 2011

Pancreatic cancer is a devastating disease. It is the fourth leading cause of cancer-related death in Germany. The incidence in 2003/2004 was 16 cases per 100.000 inhabitants. Of all carcinomas, pancreatic cancer has the highest mortality rate, with...

  • Article
  • Open Access
41 Citations
11,372 Views
12 Pages

4 May 2011

Tetrandrine is a bisbenzylisoquinoline alkaloid found in Stephania tetrandra, a Chinese medicine commonly used as an anti-inflammatory. It has extensive pharmacological activity, including positive ion channel blockade and inhibition of multiple drug...

  • Review
  • Open Access
12 Citations
8,821 Views
12 Pages

Targeted Therapy for Biliary Tract Cancer

  • Junji Furuse and
  • Takuji Okusaka

3 May 2011

It is necessary to establish effective chemotherapy to improve the survival of patients with biliary tract cancer, because most of these patients are unsuitable candidates for surgery, and even patients undergoing curative surgery often have recurren...

  • Review
  • Open Access
18 Citations
8,956 Views
19 Pages

Targeted Therapy in Nonmelanoma Skin Cancers

  • Giulia Spallone,
  • Elisabetta Botti and
  • Antonio Costanzo

3 May 2011

Nonmelanoma skin cancer (NMSC) is the most prevalent cancer in light-skinned populations, and includes mainly Basal Cell Carcinomas (BCC), representing around 75% of NMSC and Squamous Cell Carcinomas (SCC). The incidence of these tumors is continuous...

  • Review
  • Open Access
6 Citations
11,777 Views
9 Pages

28 April 2011

Genetic studies describing a link between cancer and inflammation have increased recently. Activation of the transcription factor nuclear factor-κB (NF-κB) and its effector pathways has been proposed to be the missing link between these two processes...

  • Article
  • Open Access
11 Citations
10,057 Views
20 Pages

28 April 2011

Successful cancer immunotherapy is confounded by the magnitude of the tumor burden and the presence of immunoregulatory elements that suppress an immune response. To approach these issues, 26 patients with advanced treatment refractory cancer were en...

  • Article
  • Open Access
4 Citations
7,775 Views
10 Pages

26 April 2011

We estimated the effects on the lead time for women participating in a long-term breast cancer screening program when the screening sensitivities and disease progression are independent of age. The lead time, or time by which a diagnosis is advanced...

  • Review
  • Open Access
55 Citations
13,256 Views
19 Pages

Lymph Node Metastasis of Gastric Cancer

  • Tomonori Akagi,
  • Norio Shiraishi and
  • Seigo Kitano

26 April 2011

Despite a decrease in incidence in recent decades, gastric cancer is still one of the most common causes of cancer death worldwide [1]. In areas without screening for gastric cancer, it is diagnosed late and has a high frequency of nodal involvement...

  • Article
  • Open Access
48 Citations
10,573 Views
9 Pages

26 April 2011

Colorectal cancer (CRC) is a major cause of mortality in western society with a 5-year survival of approximately 50%. Metastasis to the liver and lungs is the principal cause of death and occurs in up to 25% of patients at presentation. Despite advan...

  • Review
  • Open Access
32 Citations
9,346 Views
19 Pages

Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy

  • Gaya Spolverato,
  • Salvatore Pucciarelli,
  • Roberta Bertorelle,
  • Anita De Rossi and
  • Donato Nitti

26 April 2011

Locally advanced rectal cancer is currently treated with pre-operative radiochemotherapy (pRCT), but the response is not uniform. Identification of patients with higher likelihood of responding to pRCT is clinically relevant, as patients with resista...

  • Review
  • Open Access
11 Citations
8,664 Views
19 Pages

26 April 2011

Dendritic cells (DC) are professional antigen presenting cells that are crucial for the induction of anti-tumor T cell responses. As a consequence, research has focused on the harnessing of DCs for therapeutic interventions. Although current strategi...

  • Review
  • Open Access
130 Citations
16,644 Views
30 Pages

Wnt/β-catenin Signaling in Normal and Cancer Stem Cells

  • Kenneth C. Valkenburg,
  • Carrie R. Graveel,
  • Cassandra R. Zylstra-Diegel,
  • Zhendong Zhong and
  • Bart O. Williams

19 April 2011

The ability of Wnt ligands to initiate a signaling cascade that results in cytoplasmic stabilization of, and nuclear localization of, β-catenin underlies their ability to regulate progenitor cell differentiation. In this review, we will summarize the...

  • Review
  • Open Access
6 Citations
9,187 Views
26 Pages

Prognostic Value of Colorectal Cancer Biomarkers

  • Paolo Bianchi,
  • Luigi Laghi,
  • Gabriele Delconte and
  • Alberto Malesci

19 April 2011

Despite the large amount of data in cancer biology and many studies into the likely survival of colorectal cancer (CRC) patients, knowledge regarding the issue of CRC prognostic biomarkers remains poor. The Tumor-Node-Metastasis (TNM) staging system...

  • Review
  • Open Access
46 Citations
11,419 Views
25 Pages

Cancer Stem Cells and Side Population Cells in Breast Cancer and Metastasis

  • Kelly M. Britton,
  • John A. Kirby,
  • Thomas W.J. Lennard and
  • Annette P. Meeson

19 April 2011

In breast cancer it is never the primary tumour that is fatal; instead it is the development of metastatic disease which is the major cause of cancer related mortality. There is accumulating evidence that suggests that Cancer Stem Cells (CSC) may pla...

  • Review
  • Open Access
13 Citations
11,945 Views
21 Pages

Essential Gene Pathways for Glioblastoma Stem Cells: Clinical Implications for Prevention of Tumor Recurrence

  • Kazunari Yamada,
  • Jonathan Tso,
  • Fei Ye,
  • Jinny Choe,
  • Yue Liu,
  • Linda M. Liau and
  • Cho-Lea Tso

18 April 2011

Glioblastoma (World Health Organization/WHO grade IV) is the most common and most aggressive adult glial tumor. Patients with glioblastoma, despite being treated with gross total resection and post-operative radiation/chemotherapy, will almost always...

  • Article
  • Open Access
1 Citations
9,737 Views
18 Pages

Common Altered Epigenomic Domains in Cancer Cells: Characterization and Subtle Variations

  • Yi-Chien Tsai,
  • Chun-Hui Chiao,
  • Ian Yi-Feng Chang,
  • Dow-Tien Chen,
  • Tze-Tze Liu,
  • Kate Hua,
  • Chuan-Hsiung Chang and
  • Ming-Ta Hsu

18 April 2011

We have previously identified large megabase-sized hypomethylated zones in the genome of the breast cancer cell line MCF-7 using the TspRI-ExoIII technique. In this report, we used a more convenient high throughput method for mapping the hypomethylat...

  • Review
  • Open Access
40 Citations
11,401 Views
18 Pages

EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab’s Clinical Effects

  • Rolando Perez,
  • Ernesto Moreno,
  • Greta Garrido and
  • Tania Crombet

18 April 2011

Current clinical trials of epidermal growth factor receptor (EGFR)-targeted therapies are mostly guided by a classical approach coming from the cytotoxic paradigm. The predominant view is that the efficacy of EGFR antagonists correlates with skin ras...

  • Article
  • Open Access
36 Citations
11,301 Views
18 Pages

Glioma Specific Extracellular Missense Mutations in the First Cysteine Rich Region of Epidermal Growth Factor Receptor (EGFR) Initiate Ligand Independent Activation

  • Susie I. Ymer,
  • Sameer A. Greenall,
  • Anna Cvrljevic,
  • Diana X. Cao,
  • Jacqui F. Donoghue,
  • V. Chandana Epa,
  • Andrew M. Scott,
  • Timothy E. Adams and
  • Terrance G. Johns

18 April 2011

The epidermal growth factor receptor (EGFR) is overexpressed or mutated in glioma. Recently, a series of missense mutations in the extracellular domain (ECD) of EGFR were reported in glioma patients. Some of these mutations clustered within a cystein...

  • Review
  • Open Access
6 Citations
8,356 Views
10 Pages

Endoscopic Palliation for Pancreatic Cancer

  • Mihir Bakhru,
  • Bezawit Tekola and
  • Michel Kahaleh

13 April 2011

Pancreatic cancer is devastating due to its poor prognosis. Patients require a multidisciplinary approach to guide available options, mostly palliative because of advanced disease at presentation. Palliation including relief of biliary obstruction, g...

  • Review
  • Open Access
13 Citations
10,284 Views
18 Pages

Colon Cancer Stem Cells: Bench-to-Bedside—New Therapeutical Approaches in Clinical Oncology for Disease Breakdown

  • Simone Di Franco,
  • Pietro Mancuso,
  • Antonina Benfante,
  • Marisa Spina,
  • Flora Iovino,
  • Francesco Dieli,
  • Giorgio Stassi and
  • Matilde Todaro

13 April 2011

It is widely accepted by the scientific community that cancer, including colon cancer, is a “stem cell disease”. Until a few years ago, common opinion was that all neoplastic cells within a tumor contained tumorigenic growth capacity, but recent evid...

  • Review
  • Open Access
18 Citations
11,341 Views
18 Pages

Colorectal Cancer Stem Cells and Cell Death

  • Veronica Catalano,
  • Miriam Gaggianesi,
  • Valentina Spina,
  • Flora Iovino,
  • Francesco Dieli,
  • Giorgio Stassi and
  • Matilde Todaro

11 April 2011

Nowadays it is reported that, similarly to other solid tumors, colorectal cancer is sustained by a rare subset of cancer stem–like cells (CSCs), which survive conventional anticancer treatments, thanks to efficient mechanisms allowing escape from apo...

  • Review
  • Open Access
89 Citations
13,248 Views
22 Pages

Recent Advance in Biosensors for microRNAs Detection in Cancer

  • Silvia Catuogno,
  • Carla L. Esposito,
  • Cristina Quintavalle,
  • Laura Cerchia,
  • Gerolama Condorelli and
  • Vittorio De Franciscis

8 April 2011

MicroRNAs (miRNAs) are short non-protein-coding RNA molecules that regulate the expression of a wide variety of genes. They act by sequence-specific base pairing in the 3’ untranslated region (3’UTR) of the target mRNA leading to mRNA degradation or...

  • Review
  • Open Access
89 Citations
13,777 Views
30 Pages

Neuropilins: A New Target for Cancer Therapy

  • Camille Grandclement and
  • Christophe Borg

8 April 2011

Recent investigations highlighted strong similarities between neural crest migration during embryogenesis and metastatic processes. Indeed, some families of axon guidance molecules were also reported to participate in cancer invasion: plexins/semapho...

  • Review
  • Open Access
14 Citations
15,637 Views
23 Pages

Apoptosis and DNA Methylation

  • Huan X. Meng,
  • James A. Hackett,
  • Colm Nestor,
  • Donncha S. Dunican,
  • Monika Madej,
  • James P. Reddington,
  • Sari Pennings,
  • David J. Harrison and
  • Richard R. Meehan

1 April 2011

Epigenetic mechanisms assist in maintaining gene expression patterns and cellular properties in developing and adult tissues. The molecular pathology of disease states frequently includes perturbation of DNA and histone methylation patterns, which ca...

  • Article
  • Open Access
12 Citations
9,853 Views
23 Pages

Targeted Alpha Therapy Approach to the Management of Pancreatic Cancer

  • Barry J. Allen,
  • Syed M. Abbas Rizvi,
  • Chang F. Qu and
  • Ross C. Smith

1 April 2011

Evidence for the efficacy of targeted alpha therapy for the control of pancreatic cancer in preclinical models is reviewed. Results are given for in vitro pancreatic cancer cells and clusters and micro-metastatic cancer lesions in vivo. Two complemen...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694